tm logo
EPIVIDIAN
Live/Registered
REGISTERED AND RENEWED

on 03 Oct 2023

Last Applicant/ Owned by

4505 Emperor Blvd, #220

Durham

NC

27703

Serial Number

85624595 filed on 14th May 2012

Registration Number

4316032 registered on 09th Apr 2013

in the Principal Register

Correspondent Address

Philip J. Cardinale

SMITH ANDERSON BLOUNT DORSETT MITCHELL &

PO BOX 2611

RALEIGH, NC 27602-2611

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

EPIVIDIAN

contract medical research services for others via a proprietary database, namely, conducting pharmacovigilence studies, clinical outcomes assessment, clinical trial protocol feasibility assessment, and clinical trial candidate identification and selection; pharmaceutical information services, namely, clinical data reporting on adverse event reporting systems for pharmaceutical companies; cloud comRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


contract medical research services for others via a proprietary database, namely, conducting pharmacovigilence studies, clinical outcomes assessment, clinical trial protocol feasibility assessment, and clinical trial candidate identification and selection; pharmaceutical information services, namely, clinical data reporting on adverse event reporting systems for pharmaceutical companies; cloud computing featuring software for use by the pharmacovigilance departments of pharmaceutical companies in adverse event management and adverse event signal detection and tracking; providing cloud-based data warehousing and temporary use of non-downloadable software for clinical data reporting and business intelligence for medical records for medical practices and hospital clinics


First Use Date in General

06th May 2012

First Use Date in Commerce

06th May 2012

Class [035]
Advertising, Business & Retail Services


conducting market research via a proprietary database in the medical research field


First Use Date in General

06th May 2012

First Use Date in Commerce

06th May 2012

Specimens


EPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimenEPIVIDIAN specimen

Mark Details


Serial Number

No 85624595

Mark Type

No Service Mark

Attorney Docket Number

No 9918.3

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
03rd Oct 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03rd Oct 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03rd Oct 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02th Oct 2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
29th Sep 2023POST REGISTRATION ACTION MAILED - SEC. 8 & 9
21st Sep 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20th Jun 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20th Jun 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20th Jun 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
20th Jun 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS